Gastric Cancer
Copyright ©The Author(s) 2004.
World J Gastroenterol. Mar 15, 2004; 10(6): 776-782
Published online Mar 15, 2004. doi: 10.3748/wjg.v10.i6.776
Table 1 Relationship between clinicopathological features and heparanase mRNA expression and CD44v6, nm23 and MMP-7 protein expression in primary gastric carcinomas
Number of patients
Heparanase
CD44v6
nm23
MMP-7
(+)(-)P value(+)(-)P value(+)(-)P value(+)(-)P value
Gender0.3070.4810.2800.415
Female1341258998
Male1610215818179
Tumor location0.2160.3460.9030.804
Upper third91914664
Middle third43613452
Lower third16101889171511
Gross type0.2420.3250.0250.121
Borrmann I10100110
Borrmann II45547254
Borrmann III2192559212010
Borrmann IV30210303
Histologic type0.6710.2970.4440.325
Adenocarcinoma191123713172010
Mucinous carcinoma41501432
Signet-ring cell62532635
carcinoma
Peritoneal metastasis0.5391.0000.0450.266
Absent2614301013272317
Present30303030
Liver metastasis1.0001.0000.1330.511
Absent2714311014272417
Present20202020
Histologic differentiation1.0000.7040.8880.101
Well/moderate951045968
Poorly2092361118209
Serosal invasion0.0090.0100.1010.042
Absent26355326
Present27830511242411
Lymph node metastasis0.0180.0240.0080.084
Absent799710679
Present225243621198
Distant metastasis0.0390.6560.1251.000
Absent211426911242114
Present80715353
TNM stage0.0010.0010.2280.021
I-II410687759
III-IV254272920218
Table 2 Correlation between the expression of heparanase mRNA and the expression of CD44v6, nm23 and MMP-7 protein
ItemsNumberof casesHeparanase(+)CorrelationcoefficientP value
CD44v6-0.4400.004
(-)103
(+)3326
Nm23-0.0210.889
(-)2718
(+)1611
MMP-7-0.3520.023
(-)178
(+)26 21